Bank of America’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Bank of America’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-34,287	Closed	-$7K	–	7659
2019 Q3	$7K	Sell	34,287 -20,096	-37%	-$13.6K	﹤0.01%	6803
2019 Q2	$47K	Buy	54,383 +15,780	+41%	+$24.7K	﹤0.01%	6330
2019 Q1	$89K	Buy	38,603 +27,526	+248%	+$74.6K	﹤0.01%	5944
2018 Q4	$25K	Buy	11,077 +2,797	+34%	+$24.7K	﹤0.01%	6436
2018 Q3	$123K	Buy	8,280 +5,419	+189%	+$86.1K	﹤0.01%	5781
2018 Q2	$43K	Sell	2,861 -4,244	-60%	-$72K	﹤0.01%	6220
2018 Q1	$133K	Buy	7,105 +3,359	+90%	+$58.7K	﹤0.01%	5590
2017 Q4	$68K	Buy	3,746 +3,510	+1,487%	+$74.2K	﹤0.01%	5926
2017 Q3	$5K	Buy	+236	New	+$5.18K	﹤0.01%	6752

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America's SNNA Position: Q4 2019 in Review

Bank of America sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 34,287 shares — an estimated $7K sold.

Bank of America first reported a position in SNNA in Q3 2017 and held it in 9 quarters. The position peaked at $133K in Q1 2018. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Bank of America reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Bank of America sold 34,287 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $7K.
Bank of America first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 9 quarters.
Bank of America's Sienna Biopharmaceuticals, Inc. position peaked at $133K in Q1 2018.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.